Reduced Time Interval for Implant Placement After Extraction Socket Preservation Using the Vega Plus Implants

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversidad Catolica Santiago de Guayaquil

About this trial

This randomized controlled clinical trial aims to evaluate whether reducing the healing interval for implant placement after extraction socket preservation improves clinical and radiographic outcomes compared with the conventional waiting period. Participants requiring single-tooth extraction and implant therapy will be randomly assigned to implant placement either 4 months or 6 months after ridge preservation using the Vega Plus implant system (Klockner).

Clinical and radiographic assessments will be performed at baseline and during follow-up visits. The primary outcome will be the mean change in horizontal alveolar ridge width measured using cone-beam computed tomography (CBCT). Secondary outcomes will include vertical bone height changes measured on CBCT, implant stability measured using resonance frequency analysis (ISQ values), marginal bone level changes assessed on standardized periapical radiographs, and postoperative pain assessed using the Visual Analog Scale (VAS).

The results of this study may contribute to optimizing treatment timing and improving efficiency in implant dentistry while maintaining favorable clinical outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age: ≥ 18 years.

Good general health.

Need of extraction of incisors, canines or premolars due to carious lesion, endodontic complication, root fracture or prosthetic reason.

Presence of three intact socket walls after tooth extraction with a defect of 50% or more of the buccal wall.

Disqualifiers

< 18 years.

Compromised health. Existence of any systemic condition such as uncontrolled diabetes mellitus, cancer, HIV, disorders that compromise wound healing, chronic high dose steroid therapy, intravenous and oral bisphosphonate therapy, bone metabolic diseases, history of irradiation of the head and neck area, or any other immunosuppressive therapy that would contraindicate oral surgical treatment.

Absence of any adjacent teeth or the opposing occluding teeth.

The hopeless tooth is a molar.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Reduced time interval treatment protocol

    Procedure/Surgery

    Participants receive treatment phases with a reduced time interval between sessions according to the experimental protocol in order to evaluate whether shortening the interval improves clinical outcomes and treatment efficiency.

  • Standard time interval treatment protocol

    Procedure/Surgery

    Participants receive implant placement after extraction socket preservation following the conventional healing interval used in routine clinical practice.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Reduced time Interval treatment protocolExperimental treatment 1 intervention
Group B: Standard Time IntervalActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Mean change in horizontal alveolar ridge width (mm) measured by cone-beam computed tomography (CBCT)

Horizontal alveolar ridge width will be measured in millimeters using cone-beam computed tomography (CBCT). Measurements will be obtained at three standardized levels (1 mm, 3 mm, and 5 mm below the crestal bone). Baseline and follow-up CBCT scans will be superimposed, and the mean change in ridge width (mm) between time points will be calculated.

Time frame
Baseline (immediately after ridge preservation surgery) to 6 months after surgery (prior to implant placement)

Secondary outcomes

1

Mean change in vertical alveolar bone height (mm) measured by cone-beam computed tomography (CBCT)

Vertical alveolar bone height will be measured in millimeters using CBCT by determining the distance between the crestal bone (line C) and the apical reference line (line A). Baseline and follow-up CBCT scans will be superimposed, and the mean change in vertical bone height will be calculated.

Time frame
Baseline (immediately after ridge preservation surgery) to 6 months after surgery (prior to implant placement)
2

Mean implant stability quotient (ISQ) measured using resonance frequency analysis (Osstell IDx)

Implant stability will be measured using resonance frequency analysis with the Osstell IDx device. Implant Stability Quotient (ISQ) values will be recorded in mesiodistal and buccolingual directions, and the mean ISQ value will be calculated for each implant.

Time frame
Implant placement to prosthetic loading (approximately 3 months)
3

Mean marginal bone level change (mm) measured on standardized periapical radiographs

Marginal bone levels will be measured using standardized digital periapical radiographs obtained with a parallel technique and individualized film holders. The distance from the implant-abutment junction to the first bone-to-implant contact will be measured mesially and distally, and the mean marginal bone level change will be calculated.

Time frame
Implant placement to 2 years after prosthetic loading
4

Mean postoperative pain score measured using the Visual Analog Scale (VAS, 0-10)

Postoperative pain will be assessed using the Visual Analog Scale ranging from 0 (no pain) to 10 (worst imaginable pain). The mean pain score will be calculated.

Time frame
24 hours to 14 days after implant placement surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.